BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18799821)

  • 1. CPU0213, a novel endothelin receptor antagonist, suppresses the upregulation of matrix metalloproteinases and connexin 43 in hyperthyroid myocardium.
    Tang XY; Liu Q; Dai DZ; Dai Y
    Pharmacol Rep; 2008; 60(4):524-31. PubMed ID: 18799821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin receptor antagonist CPU0213 suppresses ventricular fibrillation in L-thyroxin induced cardiomyopathy.
    Feng Y; Dai DZ; Na T; Cui B; Wang T; Zhang Y; Dai Y
    Pharmacol Rep; 2007; 59(3):306-14. PubMed ID: 17652831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The separate roles of endothelin receptors participate in remodeling of matrix metalloproteinase and connexin 43 of cardiac fibroblasts in maladaptive response to isoproterenol.
    Peng HJ; Dai DZ; Ji H; Dai Y
    Eur J Pharmacol; 2010 May; 634(1-3):101-6. PubMed ID: 20167215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoproterenol disperses distribution of NADPH oxidase, MMP-9, and pPKCepsilon in the heart, which are mitigated by endothelin receptor antagonist CPU0213.
    Cheng YS; Dai DZ; Dai Y
    Acta Pharmacol Sin; 2009 Aug; 30(8):1099-106. PubMed ID: 19597524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated endothelin system in diabetic vascular dysfunction and early retinopathy is reversed by CPU0213 and total triterpene acids from Fructus Corni.
    Su W; Dai DZ; Liu HR; Na T; Dai Y
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1228-33. PubMed ID: 17973859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Ebihara I; Nakamura T; Tomino Y; Koide H
    Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a, and PLB in rats.
    Qi MY; Xia HJ; Dai DZ; Dai Y
    J Cardiovasc Pharmacol; 2006 Jun; 47(6):729-35. PubMed ID: 16810072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercholesterolaemia induces early renal lesions characterized by upregulation of MMP-9 and iNOS and ET(A)R: alleviated by a dual endothelin receptor antagonist CPU0213 and simvastatin.
    Luo L; Zheng YF; Dai Y; Dai DZ
    J Pharm Pharmacol; 2009 Jun; 61(6):775-80. PubMed ID: 19505368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endothelin receptor antagonist CPU0213 is more effective than aminoguanidine to attenuate isoproterenol-induced vascular abnormality by suppressing overexpression of NADPH oxidase [correction of oxidas], ETA, ETB, and MMP9 in the vasculature.
    Xu J; Li N; Dai DZ; Yu F; Dai Y
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):42-8. PubMed ID: 18594475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-induced cardiac insufficiency relating to abnormal leptin and FKBP12.6 is ameliorated by CPU0213, an endothelin receptor antagonist, which is not affected by the CYP3A suppressing effect of erythromycin.
    Cheng YS; Dai DZ; Dai Y
    J Pharm Pharmacol; 2009 May; 61(5):569-76. PubMed ID: 19405994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulated FKBP12.6 expression and upregulated endothelin signaling contribute to elevated diastolic calcium and arrhythmogenesis in rat cardiomyopathy produced by l-thyroxin.
    Zhang Y; Huang ZJ; Dai DZ; Feng Y; Na T; Tang XY; Dai Y
    Int J Cardiol; 2008 Nov; 130(3):463-71. PubMed ID: 18684528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.
    Peterson JT; Li H; Dillon L; Bryant JW
    Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
    Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
    Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of FKBP12.6 and SERCA2a contributes to acute heart failure in septic shock and is related to an up-regulated endothelin signalling pathway.
    He HB; Yu F; Dai DZ; Dai Y
    J Pharm Pharmacol; 2007 Jul; 59(7):977-84. PubMed ID: 17637193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of isoproterenol-induced downregulation of phospholamban and FKBP12.6 by CPU0213-mediated antagonism of endothelin receptors.
    Feng Y; Tang XY; Dai DZ; Dai Y
    Acta Pharmacol Sin; 2007 Nov; 28(11):1746-54. PubMed ID: 17959025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in vascular matrix metalloproteinase due to ageing and chronic hypertension: effects of endothelin receptor blockade.
    Spiers JP; Kelso EJ; Siah WF; Edge G; Song G; McDermott BJ; Hennessy M
    J Hypertens; 2005 Sep; 23(9):1717-24. PubMed ID: 16093917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testis dysfunction by isoproterenol is mediated by upregulating endothelin receptor A, leptin and protein kinase Cvarepsilon and is attenuated by an endothelin receptor antagonist CPU0213.
    Cheng YS; Dai DZ; Dai Y
    Reprod Toxicol; 2010 Jul; 29(4):421-6. PubMed ID: 20307649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CPU0213, a novel endothelin type A and type B receptor antagonist, protects against myocardial ischemia/reperfusion injury in rats.
    Wang ZY; Zhang W; Li XZ; Han Y; Chen YP; Liu Z; Xie LP; Ji Y; Lu X
    Braz J Med Biol Res; 2011 Nov; 44(11):1148-55. PubMed ID: 21915473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CPU0213, a Dual Endothelin Receptor Antagonist, on Apoptosis via Nox4-Dependent ROS in HK-2 Cells.
    Li Q; Li J; Shao H; Li XX; Yu F; Xu M
    Cell Physiol Biochem; 2016; 39(1):183-92. PubMed ID: 27336467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the endothelin receptor antagonist CPU0213, and its modulation by rifampin, on cardiac and vascular tissue following chronic isoproterenol treatment.
    Luo L; Dai DZ; Dai Y
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):757-65. PubMed ID: 18215179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.